文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Qufeng tongluo decoction decreased proteinuria in diabetic mice by protecting podocytes via promoting autophagy.

作者信息

Ni Boran, Xiao Yao, Wei Ruojun, Liu Weijing, Zhu Liwei, Liu Yifan, Ruan Zhichao, Li Jiamu, Wang Shidong, Zhao Jinxi, Huang Weijun

机构信息

Section II of Endocrinology & Nephropathy Department, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Department of Endocrinology, Guang' Anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, China.

出版信息

J Tradit Complement Med. 2023 Nov 21;14(3):312-320. doi: 10.1016/j.jtcme.2023.11.007. eCollection 2024 May.


DOI:10.1016/j.jtcme.2023.11.007
PMID:38707926
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11068988/
Abstract

BACKGROUND: Diabetic kidney disease (DKD) is one of diabetic complications, which has become the leading cause of end-stage kidney disease. In addition to angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker(ACEI/ARB) and sodium-glucose cotransporter-2 inhibitor (SGLT2i), traditional Chinese medicine (TCM) is an effective alternative treatment for DKD. In this study, the effect of Qufeng Tongluo (QFTL) decoction in decreasing proteinuria has been observed and its mechanism has been explored based on autophagy regulation in podocyte. METHODS: In vivo study, db/db mice were used as diabetes model and db/m mice as blank control. Db/db mice were treated with QFTL decoction, rapamycin, QFTL + 3-Methyladenine (3-MA), trehalose, chloroquine (CQ) and QFTL + CQ. Mice urinary albumin/creatinine (UACR), nephrin and autophagy related proteins (LC3 and p62) in kidney tissue were detected after intervention of 9 weeks. Transcriptomics was operated with the kidney tissue from model group and QFTL group. In vitro study, mouse podocyte clone-5 (MPC-5) cells were stimulated with hyperglycemic media (30 mmol/L glucose) or cultured with normal media. High-glucose-stimulated MPC-5 cells were treated with QFTL freeze-drying powder, rapamycin, CQ, trehalose, QFTL+3-MA and QFTL + CQ. Cytoskeletal actin, nephrin, ATG-5, ATG-7, Beclin-1, cathepsin L and cathepsin B were assessed. mRFP-GFP-LC3 was established by stubRFP-sensGFP-LC3 lentivirus transfection. RESULTS: QFTL decoction decreased the UACR and increased the nephrin level in kidney tissue and high-glucose-stimulated podocytes. Autophagy inhibitors, including 3-MA and chloroquine blocked the effects of QFTL decoction. Further study showed that QFTL decoction increased the LC3 expression and relieved p62 accumulation in podocytes of db/db mice. In high-glucose-stimulated MPC-5 cells, QFTL decoction rescued the inhibited LC3 and promoted the expression of ATG-5, ATG-7, and Beclin-1, while had no effect on the activity of cathepsin L and cathepsin B. Results of transcriptomics also showed that 51 autophagy related genes were regulated by QFTL decoction, including the genes of ATG10, SCOC, ATG4C, AMPK catalytic subunit, PI3K catalytic subunit, ATG3 and DRAM2. CONCLUSION: QFTL decoction decreased proteinuria and protected podocytes in db/db mice by regulating autophagy.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eac/11068988/a78f6f6d81fd/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eac/11068988/50fbc3989de8/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eac/11068988/32b55e15ddeb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eac/11068988/deb9c6fc778e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eac/11068988/c36f6255947b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eac/11068988/a78f6f6d81fd/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eac/11068988/50fbc3989de8/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eac/11068988/32b55e15ddeb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eac/11068988/deb9c6fc778e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eac/11068988/c36f6255947b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eac/11068988/a78f6f6d81fd/gr4.jpg

相似文献

[1]
Qufeng tongluo decoction decreased proteinuria in diabetic mice by protecting podocytes via promoting autophagy.

J Tradit Complement Med. 2023-11-21

[2]
Tongluo Digui decoction treats renal injury in diabetic rats by promoting autophagy of podocytes.

J Tradit Chin Med. 2021-2

[3]
Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K/Akt/mTOR signaling pathway.

J Ethnopharmacol. 2022-7-15

[4]
Qizhi Jiangtang capsule activates podocyte autophagy in diabetic kidney disease by inhibiting phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin pathways.

J Tradit Chin Med. 2023-8

[5]
Vitamin D Ameliorates Podocyte Injury by Enhancing Autophagy Activity in Diabetic Kidney Disease.

Kidney Blood Press Res. 2023

[6]
Qingfei Tongluo Mixture Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis through mTOR-Dependent Autophagy in Rats.

Mediators Inflamm. 2024

[7]
Alleviation by Mahuang Fuzi and Shenzhuo Decoction in High Glucose-Induced Podocyte Injury by Inhibiting the Activation of Wnt/-Catenin Signaling Pathway, Resulting in Activation of Podocyte Autophagy.

Evid Based Complement Alternat Med. 2020-9-3

[8]
Ameliorative effects of Modified Huangqi Chifeng decoction on podocyte injury via autophagy mediated by PI3K/AKT/mTOR and AMPK/mTOR pathways.

J Ethnopharmacol. 2024-3-1

[9]
Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.

Histol Histopathol. 2019-3-6

[10]
Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.

Acta Pharmacol Sin. 2022-1

引用本文的文献

[1]
Mechanisms of Xuefu Zhuyu decoction in treating diabetic kidney disease-induced renal fibrosis: UPLC-Q/TOF-MS, network pharmacology, and experimental validation.

Korean J Physiol Pharmacol. 2025-9-1

[2]
Novel Insights into Diabetic Kidney Disease.

Int J Mol Sci. 2024-9-23

本文引用的文献

[1]
Diosgenin Targets CaMKK2 to Alleviate Type II Diabetic Nephropathy through Improving Autophagy, Mitophagy and Mitochondrial Dynamics.

Nutrients. 2023-8-11

[2]
P2X7R/AKT/mTOR signaling mediates high glucose-induced decrease in podocyte autophagy.

Free Radic Biol Med. 2023-8-1

[3]
Arctigenin improves neuropathy via ameliorating apoptosis and modulating autophagy in streptozotocin-induced diabetic mice.

CNS Neurosci Ther. 2023-10

[4]
Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy.

Autophagy. 2023-2

[5]
Canagliflozin-associated severe hyponatremia: a rare and potentially adverse effect?

Endocrinol Diabetes Metab Case Rep. 2022-3-1

[6]
Inhibition of the Wnt/β-catenin signaling pathway reduces autophagy levels in complement treated podocytes.

Exp Ther Med. 2021-7

[7]
Deciphering the Efficacy and Mechanisms of Chinese Herbal Medicine for Diabetic Kidney Disease by Integrating Web-Based Biochemical Databases and Real-World Clinical Data: Retrospective Cohort Study.

JMIR Med Inform. 2021-5-11

[8]
Hsa_circ_0030042 regulates abnormal autophagy and protects atherosclerotic plaque stability by targeting eIF4A3.

Theranostics. 2021-3-12

[9]
Trehalose causes low-grade lysosomal stress to activate TFEB and the autophagy-lysosome biogenesis response.

Autophagy. 2021-11

[10]
Effect of San'ao decoction with scorpio and bombyx batryticatus on CVA mice model via airway inflammation and regulation of TRPA1/TRPV1/TRPV5 channels.

J Ethnopharmacol. 2021-1-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索